JusticeItaly Official institution
Italy authorizes KOKRAN, a secnidazole medicine from Italfarmaco
Italy's medicines agency AIFA has authorized the sale of KOKRAN, a prescription medicine containing secnidazole, in a decision dated 23 October 2026. Its license holder is Italfarmaco S.p.a. of Milan, and it is sold as 2 g film-coated granule sachets in packs of 1 or 3. The notice was published on 6 November 2026.
This summary was generated by AI; the official source prevails.
What does it mean?
Italy has now approved KOKRAN as a medicine that can be sold there. Because it is prescription-only, you will need a doctor's prescription to get it.
Who is affected?
Patients who may be prescribed KOKRAN and pharmacies that dispense it.